mono-ethyl methoxymalonate | 113137-31-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: mono-ethyl methoxymalonate
• 英文别名: 3-(ethyloxy)-2-(methyloxy)-3-oxopropanoic acid；3-Ethoxy-2-methoxy-3-oxopropanoic acid
• CAS: 113137-31-8
• 化学式: C₆H₁₀O₅
• 分子量: 162.142
• InChiKey: AHHOEWMSBSEQAQ-UHFFFAOYSA-N

物化性质

• 沸点：
  95 °C(Press: 3 Torr)
• 密度：
  1.224±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  72.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  mono-ethyl methoxymalonate 在 伯吉斯试剂 、 N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下， 以 二氯甲烷 、 1,2-二氯乙烷 为溶剂， 反应 0.33h， 生成 ethyl [5-(3,5-dichlorophenyl)-1,3,4-oxadiazol-2-yl](methyloxy)acetate
  参考文献：
  名称：

  WO2009/819

  摘要：

  公开号：
• 作为产物：
  描述：

  二乙基甲氧基丙二酸酯 在 氢氧化钾 作用下， 以 乙醇 、 水 为溶剂， 生成 mono-ethyl methoxymalonate
  参考文献：
  名称：

  Synergistic plant growth regulator compositions

  摘要：

  这项发明涉及含有（1）乙烯响应或类似乙烯响应诱导剂和（11）丙二酸衍生物化合物的协同植物生长调节剂组合物。该发明还涉及利用上述组合物诱导协同植物生长调节响应或乙烯响应或类似乙烯响应。

  公开号：

  US05123951A1

文献信息

• Use of malonic acid derivative compounds for retarding plant growth
  申请人：Rhone-Poulenc Inc.

  公开号：US05292937A1

  公开（公告）日：1994-03-08

  This invention relates to a method for retarding plant growth by applying to the plant an effective amount of a malonic acid derivative compound. This invention also relates to novel malonic acid derivative compounds and processes for the preparation thereof.

  这项发明涉及一种通过向植物施加丙二酸衍生物化合物的有效量来延缓植物生长的方法。该发明还涉及新颖的丙二酸衍生物化合物及其制备方法。
• Synergistic plant growth regulator compositions
  申请人：Rhone-Poulenc Nederland B.V.

  公开号：US05123951A1

  公开（公告）日：1992-06-23

  This invention relates to synergistic plant growth regulator compositions containing (1) an ethylene response or ethylene-type response inducing agent and (11) a malonic acid derivative compound. This invention also relates to the use of said compositions for inducing synergistic plant growth regulating responses or ethylene responses or ethylene-type responses.

  这项发明涉及含有（1）乙烯响应或类似乙烯响应诱导剂和（11）丙二酸衍生物化合物的协同植物生长调节剂组合物。该发明还涉及利用上述组合物诱导协同植物生长调节响应或乙烯响应或类似乙烯响应。
• Structure−Immunosuppressive Activity Relationships of New Analogues of 15-Deoxyspergualin. 1. Structural Modifications of the Hydroxyglycine Moiety
  作者：Luc Lebreton、Jocelyne Annat、Philippe Derrepas、Patrick Dutartre、Patrice Renaut

  DOI：10.1021/jm980431g

  日期：1999.1.1

  A series of new analogues of 15-deoxyspergualin (DSG), an immunosuppressive agent currently commercialized in Japan, was synthesized and tested in a graft-versus-host disease (GVHD) model in mice. Using the general concept of bioisosteric replacement, variations of the hydroxyglycine central "C" region were made in order to determine its optimum structure in terms of in vivo immunosuppressive activity. By this way, the malonic derivative 13a was discovered as the first example of a new series of potent immunosuppressive agents encompassing a retro-amide bond linked to the hexyl-guanidino moiety. Structure-activity relationships of this series were studied by synthesizing compounds 13g-i and 13k-s. Variation of the "right-amide" of 13a led to the urea 19a and the carbamates 23 and 27a which proved to be equally active as DSG in our GVHD model. Finally 27a was found to be the most potent derivative, being slightly more active than DSG in a heart allotransplantation model in rats. Due to the absence of chiral center in its structure and to its improved chemical stability compared to DSG, 27a was selected as a candidate for clinical evaluation.
• [EN] POLYMERIZABLE COMPOSITION, OPTICALLY ANISOTROPIC LAYER AND METHOD FOR MANUFACTURING THEREOF, OPTICAL COMPENSATORY ELEMENT, LIQUID CRYSTAL DISPLAY AND LIQUID CRYSTAL PROJECTOR<br/>[FR] COMPOSITION POLYMERISABLE, COUCHE ANISOTROPE DU POINT DE VUE OPTIQUE ET SON PROCEDE DE FABRICATION, ELEMENT COMPENSATEUR OPTIQUE, AFFICHAGE A CRISTAUX LIQUIDES ET PROJECTEUR A CRISTAUX LIQUIDES
  申请人：FUJI PHOTO FILM CO LTD

  公开号：WO2006011647A1

  公开（公告）日：2006-02-02

  The object of the invention is to provide a polymerizable composition which can optically compensate a liquid crystal layer under a condition for displaying black more precisely and prevent light leakage at a wide viewing angle and is suitably used for optical compensatory elements; an optically anisotropic layer containing the polymerizable composition; a method for manufacturing the optically anisotropic layer; and a liquid crystal display and a liquid crystal projector both capable of producing a high-quality image at a wide viewing angle, a high contrast, high quality images and being longer-lasting, using an optical compensatory element comprising the optically anisotropic layer. To meet the object, the polymerizable composition comprises a liquid crystal compound and a solvent comprising any one of compounds selected from an alkyl acetyl compound whose boiling point is 100 C or more, a hydroxy carboxylic acid alkyl ester compound, and an alkoxy-substituted alkyl carboxylic acid alkyl ester compound.
• [EN] 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE NOUVEAUX COMPOSÉS DE 5-PHÉNYL-1,3,4-OXADIAZOL-2-YL-ACÉTYL-4-PIPÉRIDINYLE CONVENANT COMME ANTAGONSITES DU RÉCEPTEUR DU CGRP
  申请人：GLAXO GROUP LTD

  公开号：WO2009000819A1

  公开（公告）日：2008-12-31

  [EN] The present invention relates to novel compounds that are CGRP receptor antagonists, processes for their preparation, to compositions containing them and to their use in the treatment of migraine, headache, and cluster headache.
  [FR] La présente invention concerne des nouveaux composés antagonistes du récepteur du peptide lié au gène de la calcitonine ou "CGRP" (Calcitonin Gene Related Peptide), les procédés pour les préparer, des compositions les contenant, et leur utilisation pour le traitement d'une migraine, d'une céphalée, et d'une algie vasculaire de la face.